Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer

Surgery

Volumn 140, Issue 2, 2006, Pages 161-169

  Wolfort, Ryan ^a   de Benedetti, Arrigo ^a   Nuthalapaty, Sam ^a   Yu, Herbert ^a   Chu, Quyen D ^a   Li, Benjamin D ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HISTONE H3; INITIATION FACTOR 4E; MESSENGER RNA; PROGESTERONE RECEPTOR; PROTEIN SERINE THREONINE KINASE; RNA HELICASE; TOUSLED LIKE KINASE 1B; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; ORGAN PRESERVATION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; RECURRENCE RISK; RISK FACTOR; RNA TRANSLATION; STATISTICAL ANALYSIS; UPREGULATION; WESTERN BLOTTING;

BREAST NEOPLASMS; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN-SERINE-THREONINE KINASES; RISK ASSESSMENT; TREATMENT FAILURE;

EID: 33746793215     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.05.001     Document Type: Article

References (21)

1. Rosenwald I.B., Rhoads D.B., Callanan L.D., Isselbacher K.J., and Schmidt E.V. Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. Proc Natl Acad Sci 90 (1993) 6175-6178
2. Altmann M., Edery I., Sonenberg N., and Trachsel H. Purification and characterization of protein synthesis initiation factor eIF-4E from the yeast Saccharomyces cerevisiae. Biochemistry 24 (1985) 6085-6089
3. Grifo J.A., Tahara S.M., Leis J.P., Morgan M.A., Shatkin A.J., and Merrick W.C. RNA stimulated ATPase activity of eukaryotic initiation factors. J Biol Chem 259 (1984) 8648-8654
4. Haghighat A., Mader S., Pause A., and Sonenberg N. Repression of cap-dependent translation by 4E-binding protein 1. competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J 14 (1995) 5701-5709
5. Lazaris-Karatzas A., Montine K.S., and Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345 (1990) 544-547
6. Kevil C.G., De Benedetti A., Payne D.K., Coe L.L., Laroux F.S., and Alexander J.S. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E. implications for tumor angiogenesis. Int J Cancer 65 (1996) 785-790
7. Rosenwald I.B., Lazaris-Karatzas A., Sonenberg N., and Schmidt E.V. Elevated levels of cyclin D1 in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 13 (1993) 758-763
8. Roe J.L., Durfee T., Zupan J.R., Repetti P.P., McLean B.G., and Zambryski P.C. Tousled is a nuclear serine/threonine protein kinase that requires a coiled-coil region for oligomerization and catalytic activity. J Biol Chem 272 (1997) 5838-5845
9. Sunavala-Doussabhoy G., Balakrishnan S.K., and DeBenedetti A. The radioresistance kinase TLK1B protects the cells by promoting repair of double strand breaks. BMC Mol Biol (2005) 6-19
10. Li Y., Defatta R., Sunavala-Doussabhoy G., and DeBenedetti A. A translationally regulated Tousled kinase phosphorylates histone H3 and confers radioresistance when overexpressed. Oncogene 20 (2001) 726-738
11. Li B.D.L., Gruner J.S., Abreo F., Johnson L.W., Yu H., Nawas S., et al. Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome. Ann Surg 235 (2002) 732-739
12. McClusky D., Chu Q., Yu H., Debenedetti A., Johnson L.W., Meschonat C., et al. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer. Ann Surg 242 (2005) 584-592
13. Norton K.S., McClusky D., Debenedetti A., and Li B.D.L. TLK1B is elevated with eIF4E overexpression in breast cancer. J Surg Res 116 (2004) 98-103
14. Li B.D., McDonald J.C., Nassar R., and Debenedetti A. Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression. Ann Surg 227 (1998) 756-763
15. Duncan R., Milburn S.C., and Hershey J.W. Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. heat shock effects on eIF-4F. J Biol Chem 262 (1987) 380-388
16. Rhoads R.E., Joshi-Barve S., and Rinker-Schaeffer C. Mechanism of action and regulation of protein synthesis initiation factor 4E. effects of mRNA discrimination, cellular growth rate, and oncogenesis. Prog Nucleic Acid Res Mol Biol 46 (1993) 183-219
17. DeBenedetti A., and Rhoads R.E. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci 87 (1990) 8212-8216
18. Sonenberg N., and Gingras A.C. The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr Opin Cell Biol 10 (1998) 268-275
19. Nathan C.A., Franklin S., Abreo F.W., Nassar R., De Benedetti A., and Glass J. Analysis of surgical margins with the molecular marker eIF4E. a prognostic factor in patients with head and neck cancer. J Clin Oncol 17 (1999) 2909-2914
20. Condon L., Ashman J., and Calkwell L. Overexpression of BCL-2 in squamous cell carcinoma of the larynx. a marker of radioresistance. Int J Cancer 100 (2002) 472-475
21. Nix P., Stafford N., and Calkwell L. Expression of Cox-2 protein in radioresistant laryngeal cancer. Ann Oncol 15 (2004) 797-801